“…Detected both systemically and in the BM stroma, inflammation is an important event during aging and can alter hematopoiesis ( Kovtonyuk et al., 2016 ; Helbling et al., 2019 ). As inflammation can contribute to cancer pathogenesis, one possible explanation for the development of DDL from CHIP donors is that hematopoietic lineages exhibiting pro-inflammatory phenotypes may modify the BM microenvironment and hematopoiesis to promote leukemogenesis ( Figure 2 ) ( Henry et al., 2015 ; Leimkuhler and Schneider, 2019 ). For example, chronic exposure to IL-1 reduces HSPC self-renewal capacity, skews differentiation toward myeloid lineages, hinders transplantation, and contributes to hematological malignancy ( Pietras et al., 2016 ; Arranz et al., 2017 ).…”